Cargando…
To Include or Occlude: Rational Engineering of HCV Vaccines for Humoral Immunity
Direct-acting antiviral agents have proven highly effective at treating existing hepatitis C infections but despite their availability most countries will not reach the World Health Organization targets for elimination of HCV by 2030. A prophylactic vaccine remains a high priority. Whilst early vacc...
Autores principales: | Schlotthauer, Felicia, McGregor, Joey, Drummer, Heidi E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146105/ https://www.ncbi.nlm.nih.gov/pubmed/33946211 http://dx.doi.org/10.3390/v13050805 |
Ejemplares similares
-
Enhancing the antigenicity and immunogenicity of monomeric forms of hepatitis C virus E2 for use as a preventive vaccine
por: Center, Rob J., et al.
Publicado: (2020) -
The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development
por: Cashman, Siobhán B., et al.
Publicado: (2014) -
A pan‐genotype hepatitis C virus viral vector vaccine generates T cells and neutralizing antibodies in mice
por: Donnison, Timothy, et al.
Publicado: (2022) -
Characterization of a multipurpose NS3 surface patch coordinating HCV replicase assembly and virion morphogenesis
por: Isken, Olaf, et al.
Publicado: (2022) -
Rationally designed carbohydrate-occluded epitopes elicit HIV-1 Env-specific antibodies
por: Zhu, Cheng, et al.
Publicado: (2019)